Steffen Appold

Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer.

Michael Baumann, Rosalind Perrin, Daniel Zips, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

Wolfgang Enghardt, Michael Baumann, Daniel Zips, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors

Georgy Shakirin, Nasreddin Abolmaali, Klaus Zöphel, 2010, Acta radiologica.

Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.

Matthias Guckenberger, Ursula Nestle, Michael Allgäuer, 2014, International journal of radiation oncology, biology, physics.

Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.

Matthias Guckenberger, Ursula Nestle, Michael Allgäuer, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.

Michael Baumann, Volker Hietschold, Nasreddin Abolmaali, 2012, Lung cancer.

PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial

Steffen Löck, Mechthild Krause, Michael Baumann, 2016, Trials.